Shares of Ingevity Corp (NASDAQ:NGVT) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the three analysts that cover the company, Zacks Investment Research reports. Three equities research analysts have rated the stock with a strong buy rating.

Brokerages have set a 1-year consensus target price of $51.00 for the company and are anticipating that the company will post $0.59 EPS for the current quarter, according to Zacks. Zacks has also assigned Ingevity Corp an industry rank of 49 out of 265 based on the ratings given to its competitors.

A number of research analysts have recently issued reports on NGVT shares. Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $50.00 price target (up from $44.00) on shares of Ingevity Corp in a research report on Wednesday, September 7th. Zacks Investment Research upgraded shares of Ingevity Corp from a “hold” rating to a “buy” rating and set a $49.00 price target on the stock in a research report on Tuesday, August 9th. SunTrust Banks Inc. restated a “buy” rating on shares of Ingevity Corp in a research report on Saturday, August 6th. KeyCorp started coverage on shares of Ingevity Corp in a research report on Thursday, July 7th. They issued an “overweight” rating and a $43.00 price target on the stock. Finally, BB&T Corp. started coverage on shares of Ingevity Corp in a research report on Friday, June 10th. They issued a “buy” rating and a $44.00 price target on the stock.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/zacks-ingevity-corp-nasdaqngvt-given-consensus-recommendation-of-strong-buy-by-brokerages.html

Ingevity Corp (NASDAQ:NGVT) traded up 1.07% on Tuesday, reaching $46.25. 45,449 shares of the company’s stock were exchanged. Ingevity Corp has a 12-month low of $23.00 and a 12-month high of $46.71. The firm has a 50 day moving average of $43.40 and a 200-day moving average of $36.57.

Ingevity Corp (NASDAQ:NGVT) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $0.66 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.51 by $0.15. On average, analysts expect that Ingevity Corp will post $1.92 earnings per share for the current fiscal year.

A number of hedge funds have recently modified their holdings of NGVT. Advisors Asset Management Inc. purchased a new stake in shares of Ingevity Corp during the second quarter valued at $135,000. Amalgamated Bank purchased a new stake in shares of Ingevity Corp during the second quarter valued at $221,000. PineBridge Investments L.P. purchased a new stake in shares of Ingevity Corp during the second quarter valued at $181,000. Ancora Advisors LLC purchased a new stake in shares of Ingevity Corp during the second quarter valued at $200,000. Finally, Teacher Retirement System of Texas purchased a new stake in shares of Ingevity Corp during the second quarter valued at $202,000.

Ingevity Corp Company Profile

Ingevity Corporation is a manufacturer of specialty chemicals, carbon materials and technologies. The Company operates through two segments: Performance Materials and Performance Chemicals. The Company’s specialty chemicals products serve as inputs used in a range of high performance applications, including asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants and printing inks.

5 Day Chart for NASDAQ:NGVT

Get a free copy of the Zacks research report on Ingevity Corp (NGVT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Ingevity Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Corp and related companies with MarketBeat.com's FREE daily email newsletter.